cas 1448036-85-8|| where to buy N-{4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl}-6-(1H-1,2,4-triazol-1-yl)pyridazine-3-carboxamide

Nombre del producto:N-{4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl}-6-(1H-1,2,4-triazol-1-yl)pyridazine-3-carboxamide

IUPAC Name:N-{4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl}-6-(1H-1,2,4-triazol-1-yl)pyridazine-3-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1448036-85-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1448036-85-8; Fórmula molecular:C18H15N9O3S; Punto de fusión:-; Código de sonrisas:CC1=CC=NC(NS(=O)(=O)C2=CC=C(NC(=O)C3=CC=C(N=N3)N3C=NC=N3)C=C2)=N1; Densidad:

: Número de catálogo:CM1002347; Peso molecular:437.44; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.